Factors associated with blood hydroxychloroquine level in lupus patients: renal function could be important

Abstract

Get full access to this article

View all access options for this article.

References

Tsakonas

Joseph

Esdaile

. A long-term study of hydroxychloroquine withdrawal on exacerbations in systemic lupus erythematosus. The Canadian Hydroxychloroquine Study Group. Lupus 1998; 7: 80–85.

Levey

Stevens

Schmid

. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009; 150: 604–612.

Costedoat-Chalumeau

Amoura

Hulot

. Low blood concentration of hydroxychloroquine is a marker for and predictor of disease exacerbations in patients with systemic lupus erythematosus. Arthritis Rheum 2006; 54: 3284–3290.

Costedoat-Chalumeau

Galicier

Aumaitre

. Hydroxychloroquine in systemic lupus erythematosus: Results of a French multicentre controlled trial (PLUS Study). Ann Rheum Dis 2012; Nov 10.

Furst

. Pharmacokinetics of hydroxychloroquine and chloroquine during treatment of rheumatic diseases. Lupus 1996; 5 Suppl 1: S11–5.

Bernstein

. Ocular safety of hydroxychloroquine sulfate (Plaquenil). South Med J 1992; 85: 274–279.

Stein

Bell

Ang

. Hydroxychloroquine neuromyotoxicity. J Rheumatol 2000; 27: 2927–2931.